Blockchain Registration Transaction Record

Oncotelic Leads RNA & Immunotherapy Innovation for Cancer and Rare Diseases

Oncotelic Therapeutics advances RNA-based and immunotherapy treatments for cancers and rare diseases, joining innovators like IO Biotech and Sarepta in transforming patient care.

This news matters because advancements in RNA-based and immunotherapy treatments represent a critical frontier in medical science, offering new hope for patients with aggressive cancers like glioblastoma and pancreatic cancer, which have historically low survival rates, as well as rare pediatric diseases that lack effective treatments. These innovations could significantly extend and improve lives, reduce healthcare burdens, and drive economic growth in the biotech sector, impacting millions globally who are directly or indirectly affected by these conditions.